EXHIBIT A JOINT FILING AGREEMENTJoint Filing Agreement • November 28th, 2018 • White Rock Capital Management Lp • Pharmaceutical preparations
The undersigned hereby agree that the statement on Schedule 13G with respect to the Common Stock, par value $0.001 per share, of ZIOPHARM Oncology, Inc., dated as of November 27, 2018 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
